Memorial Cancer Institute — Hollywood, Florida

Public research footprint of Memorial Cancer Institute, compiled from the ClinicalTrials.gov public registry.

120

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non Small Cell Lung Cancer · Pancreatic Cancer · Locally Advanced Unresectable Gastroesophageal Junction (GEJ)… · Carcinoma, Non-Small-Cell Lung

Recently updated registry entries

NCT06667076 — A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With… (Recruiting)
NCT04656652 — Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small… (Active Not Recruiting)
NCT07573215 — Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic… (Available)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Memorial Cancer Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.